Nikhil Meena

Professor

Last publication 2025 Last refreshed 2026-05-16

faculty

Internal Med, College of Medicine

17 h-index 124 pubs 888 cited

Biography and Research Information

OverviewAI-generated summary

Nikhil Meena's research focuses on interventional pulmonology, with a particular emphasis on bronchoscopic techniques for diagnosing and staging lung cancer. He has investigated robotic bronchoscopy platforms and electromagnetic navigation bronchoscopy, assessing their efficacy and the competency of fellows in their use. His work also extends to the yield and impact of pulmonologist-performed endobronchial ultrasound-guided transbronchial needle aspiration (EUS-B-FNA) for subdiaphragmatic lesions.

In addition to his work on lung cancer diagnostics, Dr. Meena has published research related to critical care, including the association of tocilizumab with increased fungal infections in critically ill COVID-19 patients with acute renal failure. He also explores the application of Bayesian methods in sepsis trials. His scholarship metrics include an h-index of 17, with 126 total publications and 869 citations. Key collaborators include Rajani Jagana, Sarenthia M. Epps, Barrett J. Burger, and Susanne K. Jeffus, all from the University of Arkansas for Medical Sciences.

Metrics

  • h-index: 17
  • Publications: 124
  • Citations: 888

Selected Publications

  • Real-world faceoff: EBRT vs interventions for malignant central airway obstruction (2026)
  • American Association for Bronchology and Interventional Pulmonology (AABIP) Evidence-Based Guidelines on Bronchoscopic Diagnosis and Staging of Lung Cancer (2025)
    2 citations DOI OpenAlex
  • Delivering a Regional Procedural Bootcamp for Incoming Pulmonary and Critical Care Medicine Fellows (2025)
  • Radiation exposure trends with augmented fluoroscopy and C-arm-based tomosynthesis for navigated bronchoscopy (2025)
  • 1635: INCIDENCE OF ENDOTOXIC SEPTIC SHOCK IN THE US AND CANADA (2025)
    1 citation DOI OpenAlex
  • Multicenter validation of secondary hemophagocytic lymphohistiocytosis diagnostic criteria (2025)
    21 citations DOI OpenAlex
  • Evaluating the Effect of Body Mass Index on Procalcitonin Level in Patients with Pneumonia: A Retrospective Cross-Sectional Study (2025)
  • Meta-analysis and systematic review of mediastinal cryobiopsy versus endobronchial ultrasound-transbronchial needle aspiration (EBUS-TBNA) in the diagnosis of intrathoracic adenopathy (2024)
    11 citations DOI OpenAlex
  • Correction to: Bayesian methods: a potential path forward for sepsis trials (2024)
  • Bayesian methods: a potential path forward for sepsis trials (2023)
    12 citations DOI OpenAlex
  • Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study (2023)
    8 citations DOI OpenAlex
  • One- versus two-specimen Xpert strategy to discontinue airborne isolation in suspected pulmonary tuberculosis: systematic review and meta-analysis (2023)
    2 citations DOI OpenAlex
  • The yield and impact of pulmonologist-performed EUS-B-FNA of subdiaphragmatic lesions—an institutional experience (2023)
    4 citations DOI OpenAlex
  • Bronchocutaneous Fistula Without Pneumothorax: A Rare Complication of Tube Thoracostomy (2023)
  • Case of Persistent Wheeze and Atelectasis in an Adolescent Male (2023)

View all publications on OpenAlex →

Grants & Funding

  • A randomized, double-blind, placebo-controlled clinical trial of once-daily inhaled molgramostim nebulizer solution in adult subjects with autoimmune pulmonary alveolar proteinosis (aPAP) (IRB 262319) Savara, Inc Principal Investigator
  • No FP attached GlaxoSmithKline - Pass Through: PPD Development, LP Principal Investigator
  • A Prospective, Multicenter, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of PMX Cartridge in Addition to Standard Medical Care for Patients with Endotoxemic Septic Shock: TIGRIS TRIAL (IRB 262982) Spectral Medical, Inc Principal Investigator
  • A randomized, double-blind, placebo-controlled clinical trial of once-daily inhaled molgramostim nebulizer solution in adult subjects with autoimmune pulmonary alveolar proteinosis (aPAP) (IRB 262319) Savara, Inc Principal Investigator
  • A Multicenter Platform Trial of Putative Therapeutics for the Treatment of COVID-19 in Hospitalized Adults (IRB 262510) NIH/Nat. Inst. of Allergy & Infectious Diseases - Pass Through: Leidos Principal Investigator
  • No FP attached Pharmerit International Principal Investigator
  • No FP attached Genentech, Inc. - Pass Through: PPD Development, LP Principal Investigator

Collaboration Network

156 Collaborators 93 Institutions 5 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics